This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Zhejiang University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,364 
1 out of 1,280 
Years Active: 2025
Title: Innovations of Rong Sheng in Anti-Tumor Research
Introduction
Rong Sheng is an accomplished inventor based in Hangzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific cancer pathways. His work focuses on creating effective treatments for tumors, showcasing his dedication to advancing medical science.
Latest Patents
Rong Sheng holds a patent for "Aminoquinazolinone and aminoisoquinolinone derivatives and application thereof." This patent describes amino quinazolinone and amino isoquinolone derivatives that have been verified through numerous experiments to exhibit strong inhibiting effects on PI3Kα and PI3Kγ. The compounds demonstrate a prominent inhibiting effect on PI3Kα and show significant growth-inhibiting effects on PIK3CA mutant tumor cells, such as the human breast cancer cell strain MCF7. These derivatives can be utilized in the preparation of anti-tumor and anti-inflammatory medicines, serving as PI3Kα inhibitors for treating tumors related to cell proliferation in humans and animals.
Career Highlights
Rong Sheng has worked with prestigious institutions, including Zhejiang University and the Chinese Academy of Sciences. His research has contributed to the understanding of cancer treatment and the development of new therapeutic agents. His innovative approach and dedication to research have positioned him as a notable figure in his field.
Collaborations
Rong Sheng has collaborated with esteemed colleagues, including Mengmeng Zhang and Dongyan Gu. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.
Conclusion
Rong Sheng's contributions to the field of anti-tumor research through his innovative patents and collaborations highlight his commitment to improving cancer treatment. His work continues to inspire advancements in medicinal chemistry and offers hope for effective therapies against challenging diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile